BL
TEVA icon

BFSG LLC’s Teva Pharmaceuticals TEVA Stock Holding History

BFSG LLC’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$155K Sell
4,567
-1,971
-30% -$65.6K 0.01% 325
2026
Q1 		$197K Sell
6,538
-1,732
-21% -$55.7K 0.02% 277
2025
Q4 		$258K Sell
8,270
-520
-6% -$12.8K 0.03% 240
2025
Q3 		$178K Sell
8,790
-2,170
-20% -$38.1K 0.02% 286
2025
Q2 		$184K Hold
10,960
– – 0.02% 261
2025
Q1 		$168K Buy
10,960
+790
+8% +$14.1K 0.02% 255
2024
Q4 		$224K Sell
10,170
-745
-7% -$13.6K 0.03% 225
2024
Q3 		$197K Sell
10,915
-2,490
-19% -$43.6K 0.02% 252
2024
Q2 		$218K Sell
13,405
-1,275
-9% -$19.6K 0.03% 226
2024
Q1 		$207K Hold
14,680
– – 0.03% 234
2023
Q4 		$153K Sell
14,680
-860
-6% -$8.03K 0.02% 269
2023
Q3 		$159K Buy
+15,540
New +$145K 0.03% 234

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

BFSG LLC's TEVA Position: Q2 2026 in Review

BFSG LLC reduced its Teva Pharmaceuticals (TEVA) stake by 30% in Q2 2026, selling an estimated $65.6K and leaving 4,567 shares worth $155K. The position accounts for 0.01% of the portfolio, ranked #325.

BFSG LLC first reported a position in TEVA in Q3 2023 and has held it in 12 quarters since. The position peaked at $258K in Q4 2025. 675 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • BFSG LLC held 4,567 shares of Teva Pharmaceuticals worth $155K as of Q2 2026.
  • BFSG LLC sold 1,971 Teva Pharmaceuticals shares in Q2 2026, an estimated $65.6K.
  • Teva Pharmaceuticals made up 0.01% of BFSG LLC's portfolio in Q2 2026, its #325 holding.
  • BFSG LLC first reported a position in Teva Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
  • BFSG LLC's Teva Pharmaceuticals position peaked at $258K in Q4 2025.
  • 675 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on BFSG LLC's 13F filing for Q2 2026, filed 20 Jul 2026.